Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
First Claim
1. A powder composition comprising a plurality of microparticles, the microparticles comprising an active agent and a metal ion-lipid complex, and the powder composition has a metal ion concentration of greater than 0 and up to and including 25% w/w, and a lipid concentration of 25-90% w/w, and wherein the density of the microparticles as measured by He displacement is 0.5-2.0 g/ml and the Tg of the microparticles is at least 2°
- C. greater than that of microparticles without the metal ion.
6 Assignments
0 Petitions
Accused Products
Abstract
Microparticle compositions comprising metal ion-lipid complexes for drug delivery are described including methods of making the microparticle compositions and methods of treating certain conditions and disease states by administering the microparticle compositions. The metal ion-lipid complexes can be combined with various drugs or active agents for therapeutic administration. The microparticle compositions of the present invention have superior stability to other microparticle compositions resulting in a microparticle composition with longer shelf life and improved dispersability. The microparticle compositions of the present invention have a transition temperature Tm of at least 20° C. above the recommended storage temperature (Tst) for drug delivery.
-
Citations
43 Claims
-
1. A powder composition comprising a plurality of microparticles, the microparticles comprising an active agent and a metal ion-lipid complex, and the powder composition has a metal ion concentration of greater than 0 and up to and including 25% w/w, and a lipid concentration of 25-90% w/w, and wherein the density of the microparticles as measured by He displacement is 0.5-2.0 g/ml and the Tg of the microparticles is at least 2°
- C. greater than that of microparticles without the metal ion.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 32, 33, 34, 35, 38, 40)
- 19. A powder composition comprising a plurality of microparticles, the microparticles comprising an active agent, a metal ion, and a phospholipid, wherein the metal ion forms a coordination bond with the phospholipid, and the powder composition has a metal ion concentration of greater than 0 and up to and including 25% w/w, and a phospholipid concentration of 25-90% w/w, and wherein the density of the particle as measured by He displacement is at least 0.5-2.0 g/ml and the transition temperature of the microparticle exceeds its storage temperature by at least 20°
-
42. A powder composition comprising a plurality of microparticles, the microparticles comprising an active agent and a metal ion-lipid complex, and the powder composition has a metal ion concentration of greater than 0 and up to and including 25% w/w, and a lipid concentration of 25-90% w/w, wherein the Tg of the microparticles is at least 2°
- C. greater than that of microparticles without the metal ion, and wherein the active agent is selected from the group consisting of albuterol, budesonide, fluticasone, salmeterol, formoterol, nicotine, triamcinolone, dexamethasone, beclomethasone, gentamicin, ciprofloxacin, paclitaxel, amphotericin, amikacin, tobramycin, insulin, human growth hormone, and salts thereof.
- View Dependent Claims (43)
Specification